In the BioHarmony Drug Report Database
Nadolol
Corgard (nadolol) is a small molecule pharmaceutical. Nadolol was first approved as Corgard on 1982-01-01. It is used to treat angina pectoris, heart failure, hypertension, and myocardial infarction in the USA. The pharmaceutical is active against beta-1 adrenergic receptor and beta-2 adrenergic receptor. In addition, it is known to target beta-3 adrenergic receptor.
Trade Name
|
Corgard |
|---|---|
Common Name
|
nadolol |
ChEMBL ID
|
CHEMBL649 |
Indication
|
angina pectoris, heart failure, hypertension, myocardial infarction |
Drug Class
|
Analgesics (mixed opiate receptor agonists/antagonists); beta-blockers (propranolol type) |
Image (chem structure or protein)